跳至主要内容
临床试验/EUCTR2016-005031-32-FI
EUCTR2016-005031-32-FI进行中(未招募)1 期

Metformin use to improve pregnancy outcome in women with type 1 diabetes. A double-blind placebo-controlled multicenter study.

Pirkanmaan sairaanhoitopiiri0 个研究点目标入组 200 人开始时间: 2017年9月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • A pregnancy of a women dealing with type 1 diabetes.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria for the study are a twin pregnancy, another significant underlying disease, severe complications of diabetes, substance abuse problems, smoking, underweight or strong early pregnancy nausea.

研究者

发起方
Pirkanmaan sairaanhoitopiiri

相似试验